N/A N=23

App-Assisted Day Reconstruction to Reduce Logistic Toxicity in Cancer

Cancer

Bottom Line

View on ClinicalTrials.gov: NCT05502302 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Jul 2024

Primary outcome: Primary: Interviews — 20 Interviews

Study Design & Population

Study type: Observational
Phase: N/A
Interventions: —
Age: Adult, Older Adult · 18+ yrs
Sex: All
Sponsor: Masonic Cancer Center, University of Minnesota
Primary completion: Feb 2023

Outcome Measures

Outcome	Result	p-value
PRIMARY Interviews	20	—
PRIMARY Satisfaction Score Follow-Up Survey	80	—

Summary

The number of new cases of cancer diagnosed in the U.S. was 1.7 million in 2017 and is expected to increase by 35% to 2.3 million in 2030[1]. Cancer treatments often create numerous logistic challenges in prioritizing and managing treatment and everyday life priorities and how these challenges affect their everyday lives and well-being (hence "logistic toxicity"). However, there are no established reliable tools to monitor patients' logistic challenges and the associated impacts; and logistic toxicity has been largely unaddressed in cancer care delivery. The objective is to develop the first digital health app for cancer patients to continuously monitor logistic toxicity in their daily lives. The app will combine objective data from mobile sensing with subjective self-reported data to form an app-assisted day reconstruction system that captures activity engagement and well-being information associated with cancer treatment-related activities and trips throughout the day.

Eligibility Criteria

Inclusion Criteria

18 years of age, currently receiving treatment for cancer, able to read/write/speak in English, and able to provide voluntary informed consent.

Exclusion Criteria

Those who are currently incarcerated or have opted out of research contact within M Health Fairview system.

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT05502302). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.